Side effects and watch-outs
- Very low oral bioavailability — injectable form higher but impractical
- Sleep disruption if dosed late
- Headache
- Nausea
- Limited human clinical data
- Circadian effects — dose timing is critical
SARM / REV-ERB Agonist
SR9009 (Stenabolic)
REV-ERBα/β agonist (circadian rhythm regulator — NOT technically a SARM). Improves endurance, fat loss, and metabolic rate. Very short half-life requires 4–5 doses daily spaced every 3–4 hours.
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.